KV PHARMACEUTICAL CO /DE/
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: KV PHARMACEUTICAL CO /DE/, 10-Q, 2000-08-14
Next: QUENTRA NETWORKS INC, 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              MAR-31-2001
<PERIOD-START>                                 APR-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         4,089
<SECURITIES>                                   0
<RECEIVABLES>                                  25,518
<ALLOWANCES>                                   622
<INVENTORY>                                    31,189
<CURRENT-ASSETS>                               68,127
<PP&E>                                         52,628
<DEPRECIATION>                                 19,579
<TOTAL-ASSETS>                                 147,986
<CURRENT-LIABILITIES>                          20,409
<BONDS>                                        5,682
                          0
                                    2
<COMMON>                                       193
<OTHER-SE>                                     106,277
<TOTAL-LIABILITY-AND-EQUITY>                   147,986
<SALES>                                        38,810
<TOTAL-REVENUES>                               38,834
<CGS>                                          0
<TOTAL-COSTS>                                  16,195
<OTHER-EXPENSES>                               15,325
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             350
<INCOME-PRETAX>                                6,964
<INCOME-TAX>                                   2,611
<INCOME-CONTINUING>                            4,353
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   4,353
<EPS-BASIC>                                    0.22
<EPS-DILUTED>                                  0.21




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission